Primary prevention, cardiovascular risk optimization in cancer patients: the role of lifestyle and drug therapy
Juhász Ágnes, Hajdú Anett, Dank Magdolna
Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest
Prof. dr. Dank Magdolna
Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, 1083 Budapest, Tömő utca 25–29.
Cardiovascular toxicity of antitumor treatments requires special attention among oncologists and cardiologists, which has led to a new interdisciplinary approach in the field of cardio-oncology. A growing body of evidence points to a clear link between risk factors and cardiovascular and cancer diseases. Smoking, obesity, improper nutrition and an inactive lifestyle all increase the development of cardiovascular and tumor diseases, which at the same time can adversely affect the outcome of oncology treatments, thereby increasing early mortality. Knowledge of common risk factors is important for prevention, and by eliminating them and changing lifestyle as soon as possible, you can provide more effective support during treatment, as a result of which mortality will decrease and the quality of life of patients will show a positive trend.
ISSUE: CARDIOLOGIA HUNGARICA | 2023 | VOLUME 53, ISSUE 2
click here to read the full article
click here to read the pdf
|Watch the video summary|